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Purpose
Maternal cells routinely pass into the fetus, with increased
frequency during complicated pregnancies. Engraftment of
maternal cells into fetal organs such as heart and kidney
may persist for decades after birth. Thus, SLE target
organs normally harbor maternal cells that may express
immunoreactive maternal proteins not shared by the
child. Loss of tolerance to non-shared maternal antigens
could lead to chronic activation of the child’s T lympho-
cytes, with subsequent autoimmunity through a mechan-
ism of epitope spreading, similar to the graft-versus-host
disease seen after transplantation of parental stem cells in
animal models.
Methods
PBMC from 26 pediatric SLE patients and 35 age-matched
controls were stimulated with maternal or unrelated donor
PBMC for 5 days. Cytokine expression and proliferation in
T cell subsets was assayed by flow cytometry. Maternal
microchimerism was assayed by Real-Time QPCR amplifi-
cation of non-shared maternal alleles using >100,000 gen-
ome equivalents of genomic DNA isolated from PBMC.
SLE disease activity was assessed by SELENA-SLEDAI.
Pregnancy history was obtained from 78 SLE patients,
56 healthy controls, 37 scleroderma, and 16 Raynaud
Phenomenon patients by parental report.
Results
T lymphocytes in patients with SLE were hyperactive in
response to maternal cells. Proliferation of CD4+ T lym-
phocytes in response to maternal cells was increased 2-
fold in SLE patients compared to controls, and IFN-g pro-
duction by CD4+ lymphocytes was increased in patients
with active SLE (SLEDAI>4), but not in those in remission
or controls. TNF-a production by CD4+ T lymphocytes
specific for maternal cells correlated with SLE disease
activity. Levels of maternal microchimerism were not
increased in SLE patients with active disease, but rather
tended to be lower (75.6 per million maternal cells in con-
trols, SD 282, versus 3.3 in SLE, SD 11, P=0.06). Of con-
trols tested, MMc was detected in 34%, compared to 23%
of SLE patients (P=0.4). Of the seven SLE patients with
MMc, three had a history of premature birth (<35 weeks)
with low birth weight (LBW, range 1.96-2.27 Kg). Overall,
SLE patients had an increased prevalence of prematurity
(15.4%) and LBW (<2.5 Kg, 14.7%) compared to local con-
trols (no prematurity or LBW was reported), patients with
scleroderma (10.8% prematurity, 8.3% LBW), Raynaud
Phenomenon without underlying systemic disease (6.3%
prematurity, 6.3% LBW), or historic national frequencies
(5-8%).
Conclusion
Elevated CD4+ T lymphocyte responses to maternal cells
are consistent with a model of persistent T lymphocyte
activation by chimeric maternal cells within target organs.
Low levels of MMc in the blood suggest immune-
mediated elimination of chimeric maternal cells in the per-
iphery. Increased maternal-fetal cell traffic during delivery
of premature infants and/or development of tolerance to
maternal antigens during the last trimester may influence
later responses to engrafted maternal cells in the child.
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